pipeline

Biotech

AstraZeneca culls neuroscience meds in Q1 clear-out

AstraZeneca has axed three MedImmune legacy monoclonal antibody drugs from its neuroscience pipeline.

Ben Adams Apr 29, 2025 7:08am

Caribou antlers sitting on ground with mountains in background

Caribou cuts 32% of staff, further purges cell therapy pipeline

Apr 24, 2025 9:55pm

a lot of scissors

Evotec axes 30% of assets as cost-cutting push hits pipeline

Apr 17, 2025 9:45am

Whirlpool in water

Cyclacel sheds clinical asset in effort to stop cash spiral

Apr 2, 2025 6:01pm

china chinese Asia

ImmuneOnco axes CD47 bispecific amid pipeline prioritization

Mar 26, 2025 6:21am

too many options

Adaptimmune questions own longevity, axes preclinical funding

Mar 20, 2025 2:04pm